55 related articles for article (PubMed ID: 36596047)
1. LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis.
Wang X; Chen Z; Zhou H; Liu W; Luo J
Medicine (Baltimore); 2022 Dec; 101(52):e32436. PubMed ID: 36596047
[TBL] [Abstract][Full Text] [Related]
2. LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis.
Tang L; Liu QM; Zhang S; Zhou J
Expert Rev Mol Diagn; 2023; 23(12):1263-1272. PubMed ID: 37902251
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of long non-coding RNA LOXL1-AS1 functions as an oncogene in cervical squamous cell carcinoma by sponging miR-21.
Bai H; Li X; Wu S
Arch Physiol Biochem; 2023 Feb; 129(1):143-147. PubMed ID: 32881598
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis.
Zhou X; Fan YH; Wang Y; Wang F; Liu Y
Medicine (Baltimore); 2019 Apr; 98(17):e15251. PubMed ID: 31027073
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of long noncoding RNA TTN-AS1 in various malignancies.
Lin G; Liu X; Cong C; Xu L
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1876. PubMed ID: 37528740
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LOXL1-AS1 promotes proliferation and invasion and inhibits apoptosis in retinoblastoma by regulating the MAPK signaling pathway.
Wu W; Zhang Y; Xu C; Yang H; Liu S; Huang G
Mol Cell Biochem; 2024 Apr; 479(4):1011-1022. PubMed ID: 37273040
[TBL] [Abstract][Full Text] [Related]
7. Potential role of lncRNA LOXL1-AS1 in human cancer development: a narrative review.
Tang M; Rong Y; Liu S; Wu Z; Ma G; Li X; Cai H
Transl Cancer Res; 2024 Apr; 13(4):1997-2011. PubMed ID: 38737681
[TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase-like 1-antisense 1 (LOXL1-AS1) lncRNA differentially regulates gene and protein expression, signaling and morphology of human ocular cells.
Schmitt HM; Hake KM; Perkumas KM; Lê BM; Suarez MF; De Ieso ML; Rahman RS; Johnson WM; Gomez-Caraballo M; Ashley-Koch AE; Hauser MA; Stamer WD
Hum Mol Genet; 2023 Oct; 32(21):3053-3062. PubMed ID: 37540217
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the expression of lncRNA MALAT1 and clinical features and prognosis in bladder cancer: A meta-analysis.
Su Y; Chen H; Yao L; Dai H; Liu H
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):166-171. PubMed ID: 38279449
[TBL] [Abstract][Full Text] [Related]
10. Correlation between long non-coding RNA MAFG-AS1 and cancer prognosis: a meta-analysis.
Lin G; Liu H; Lin J; Liu X; Xu L
Front Oncol; 2023; 13():1286610. PubMed ID: 38130989
[TBL] [Abstract][Full Text] [Related]
11. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer.
Li C; Chen S; Fang X; Du Y; Guan XY; Lin R; Xu L; Lan P; Yan Q
Cell Biol Toxicol; 2024 Jan; 40(1):6. PubMed ID: 38267662
[TBL] [Abstract][Full Text] [Related]
12. CEMIP as a prognostic biomarker for cancers: a meta- and bioinformatic analysis.
Chen H; Wang Q; Liu J; Chen Y; Zhang Q; Chai L; Wang Y; Li D; Qiu Y; Li M
Expert Rev Mol Diagn; 2022 Dec; 22(12):1107-1115. PubMed ID: 36631437
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DARS-AS1 in human cancers: A comprehensive review of its potency as a biomarker and therapeutic target.
Dang Q
Gene; 2024 Sep; 923():148566. PubMed ID: 38762015
[TBL] [Abstract][Full Text] [Related]
14. Prognostic utility and clinical significance of lysyl oxidase-like 2 protein expression in digestive system cancers.
Zhang Y; Liu W; Xu J
J Cell Physiol; 2019 Nov; 234(11):20713-20720. PubMed ID: 30997684
[TBL] [Abstract][Full Text] [Related]
15. Expression level and clinical significance of NBAT-1 in human cancers: a systematic review and meta-analysis.
Yu Y; Fan K; Ni T; Zhang XL; Su X; Yang L
BMC Cancer; 2024 Jan; 24(1):109. PubMed ID: 38243168
[TBL] [Abstract][Full Text] [Related]
16. High expression of ANRIL correlated with the poor prognosis in patients with cancer: A meta-analysis.
Liu Y; Zhu L; Zhao W; Zhou Y; Shao S
Medicine (Baltimore); 2022 Sep; 101(36):e30531. PubMed ID: 36086708
[TBL] [Abstract][Full Text] [Related]
17. Clinical role of the long non‑coding RNA, EGFR‑AS1, in patients with cancer: A systematic review and meta‑analysis.
Zhu L; Zhang J; Zhou H; Zhang G; Wang B; Qi H
Oncol Lett; 2024 May; 27(5):199. PubMed ID: 38516689
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis.
Zhang Y; Xu L; Peng M
Onco Targets Ther; 2018; 11():1045-1054. PubMed ID: 29520155
[TBL] [Abstract][Full Text] [Related]
19. LOXL1-AS1 Drives the Progression of Gastric Cancer via Regulating miR-142-5p/PIK3CA Axis [Retraction].
Onco Targets Ther; 2023; 16():473-474. PubMed ID: 37396313
[TBL] [Abstract][Full Text] [Related]
20. LOXL1-AS1 Aggravates Myocardial Ischemia/Reperfusion Injury Through the miR-761/PTEN Axis.
He W; Duan L; Zhang L
Korean Circ J; 2023 Jun; 53(6):387-403. PubMed ID: 37161797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
